Patents by Inventor Sayon ROY

Sayon ROY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Closed loop monitoring based privileged access control
    Patent number: 11368377
    Abstract: In some examples, closed loop monitoring based privileged access control may include identifying a ticket that includes a specification of an incident that is to be remedied and determining an intent of the ticket. A privileged access command library may be analyzed to determine a plurality of privileged access steps that can be performed to remedy the incident. A source file associated with procedures that were performed to remedy the incident may be analyzed. A plurality of events may be identified using the source file and filtered based on the plurality of privileged access steps that can be performed to remedy the incident. At least one event that includes at least one other privileged access step that is not one of the plurality of privileged access steps that can be performed to remedy the incident may be identified, and instructions may be generated to remedy the identified event.
    Type: Grant
    Filed: December 16, 2020
    Date of Patent: June 21, 2022
    Assignee: ACCENTURE GLOBAL SOLUTIONS LIMITED
    Inventors: Sanjeev Shukla, Gaurav Tandon, Chetan Kulshrestha, Alok Panda, Sayon Roy Choudhury, Anil Vilas Renuse, Catherine Marie-Luise Ploehn
  • Gap junction intercellular communication modulators and their use for the treatment of diabetic eye disease
    Patent number: 11324799
    Abstract: The use of gap junction intercellular communication (GJIC) modulators in the treatment or prevention of diabetic eye disease is disclosed, and more particularly to their use for the treatment or prevention of early stage diabetic retinopathy and diabetic macular edema by inhibiting apoptosis of retinal endothelial cells and inhibiting pericyte loss.
    Type: Grant
    Filed: May 4, 2018
    Date of Patent: May 10, 2022
    Assignees: ZEALAND PHARMA A/S, BOSTON MEDICAL CENTER CORPORATION
    Inventors: Bjarne Due Larsen, Ulrik Mouritzen, Dongjoon Kim, Sayon Roy
  • CLOSED LOOP MONITORING BASED PRIVILEGED ACCESS CONTROL
    Publication number: 20210367864
    Abstract: In some examples, closed loop monitoring based privileged access control may include identifying a ticket that includes a specification of an incident that is to be remedied and determining an intent of the ticket. A privileged access command library may be analyzed to determine a plurality of privileged access steps that can be performed to remedy the incident. A source file associated with procedures that were performed to remedy the incident may be analyzed. A plurality of events may be identified using the source file and filtered based on the plurality of privileged access steps that can be performed to remedy the incident. At least one event that includes at least one other privileged access step that is not one of the plurality of privileged access steps that can be performed to remedy the incident may be identified, and instructions may be generated to remedy the identified event.
    Type: Application
    Filed: December 16, 2020
    Publication date: November 25, 2021
    Applicant: ACCENTURE GLOBAL SOLUTIONS LIMITED
    Inventors: Sanjeev SHUKLA, Gaurav TANDON, Chetan KULSHRESTHA, Alok PANDA, Sayon Roy CHOUDHURY, Anil Vilas RENUSE, Catherine Marie-Luise PLOEHN
  • GAP JUNCTION INTERCELLULAR COMMUNICATION MODULATORS AND THEIR USE FOR THE TREATMENT OF DIABETIC EYE DISEASE
    Publication number: 20200054602
    Abstract: The use of gap junction intercellular communication (GJIC) modulators in the treatment or prevention of diabetic eye disease is disclosed, and more particularly to their use for the treatment or prevention of early stage diabetic retinopathy and diabetic macular edema by inhibiting apoptosis of retinal endothelial cells and inhibiting pericyte loss.
    Type: Application
    Filed: May 4, 2018
    Publication date: February 20, 2020
    Applicants: ZEALAND PHARMA A/S, BOSTON MEDICAL CENTER CORPORATION
    Inventors: Bjarne Due LARSEN, Ulrik MOURITZEN, Dongjoon KIM, Sayon ROY